Broschüre zum Investitionsprojekt DR03 (PDF ... - GlaxoSmithKline

glaxosmithkline

Broschüre zum Investitionsprojekt DR03 (PDF ... - GlaxoSmithKline

the demand for flu vaccines expands globally,

GlaxoSmithKline is the world’s third

largest supplier of flu vaccines and still

growing. Until 2005 the annual vaccine

production in Dresden was continuously

increased from formerly 2 million to 35

million syringes. Beside this optimi zed

uti lisation of the existing capacities and

the acquisition of an additional site in

canada, GlaxoSmithKline focuses on expanded

manufacturing capacities.

In August 2005 there was the groundbreaking

ceremony of the new buildings

in Dresden and in February 2008 the new

facilities were put into operation yet,

which allow to produce twice as many

so called monobulks. In order to subsequently

process these huge quantities

of inactivated split virus solutions to the

final vaccine, GlaxoSmithKline Biologicals

invested additional 25 million Euro in new

capacities for formulation, filling and inspection

– installed in already existing

buildings.

impfung

inkubation

Sichtung

Ernte

fällung

Separation

ultrafiltration

ultrazentrifugation

filtration

inaktivierung

Reinigung

Sterilisation

Medienherstellung

Poolung

this project’s special challenge is up to the

fact that all activities from demolition,

construction and interior work to plant

installations had to take place while we

continued manufacturing in these buildings.

complementary two new lifts

pro vide for an improved flow of material

and people in the future, such as the

new docking station for delivery of raw

mate rials and for despatch of the finished

goods offers optimised conditions concerning

production conform to requirements

(Good manufacturing Practice).

Herstellungsprozess

Production process

Abfüllung

Sichtung

Konfektionierung

5

Weitere Magazine dieses Users
Ähnliche Magazine